driven by the PitchBook Platform
Developer of a technology intended to facilitate the delivery of double-stranded oligonucleotide therapeutics to multiple cell types and tissues. The company is currently operating in Stealth mode.
You’re viewing a free company profile from the PitchBook Platform. To explore DTx Pharma’s full profile, request a free trial.
© 2018 PitchBook Data. All rights reserved. PitchBook is a financial technology company that provides data on the capital markets.